JE Frampton - American Journal of Cardiovascular Drugs, 2023 - Springer
Inclisiran (Leqvio®) is a first-in-class, subcutaneously administered, small interfering RNA
(siRNA) that prevents hepatic synthesis of proprotein convertase subtilisin/kexin type 9 …